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Calcium nephrolithiasis in children is increasing in prevalence
and tends to be recurrent. Although children have a lower
incidence of nephrolithiasis than adults, its etiology in
children is less well understood; hence, treatments targeted
for adults may not be optimal in children. To better
understand metabolic abnormalities in stone-forming
children, we compared chemical measurements and the
crystallization properties of 24-h urine collections from 129
stone formers matched to 105 non-stone-forming siblings
and 183 normal, healthy children with no family history of
stones, all aged 6 to 17 years. The principal risk factor for
calcium stone formation was hypercalciuria. Stone formers
have strikingly higher calcium excretion along with high
supersaturation for calcium oxalate and calcium phosphate,
and a reduced distance between the upper limit of
metastability and supersaturation for calcium phosphate,
indicating increased risk of calcium phosphate crystallization.
Other differences in urine chemistry that exist between adult
stone formers and normal individuals such as hyperoxaluria,
hypocitraturia, abnormal urine pH, and low urine volume
were not found in these children. Hence, hypercalciuria and
a reduction in the gap between calcium phosphate upper
limit of metastability and supersaturation are crucial
determinants of stone risk. This highlights the importance
of managing hypercalciuria in children with calcium stones.
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Among adults, recognized risk factors for calcium kidney stone
formation in the absence of systemic diseases include familial
(idiopathic) hypercalciuria, hyperoxaluria, hypocitraturia, low
urine volume, and hyperuricosuria.1–3 They are, in the main,
thought to produce stones via the final common pathway of
increased urine supersaturation (SS) with respect to stone-forming
salts4–6 or, in the case of hyperuricosuria, via alteration of calcium
oxalate (CaOx) salt solubility.7 Whether this ensemble of causes
pertains to equivalent force for children has not been well tested.
Hypercalciuria has certainly been identified as a potential risk
factor,8–10 but missing is a comparison of stone-forming children
with age- and sex-matched non-stone-forming children using
sufficient numbers of subjects to test for important differences in
all urine stone risk factors both compared with healthy children
and non-stone-forming siblings of stone-forming children.10–15
Accordingly, a strength of the study presented here is the
large and diverse population of children derived from six
practices across the United States who treat primarily pediatric
patients. We have obtained 24-h urine collections from 417
children: 129 with calcium stones (stone former, SF), 105 non-
stone-forming siblings (NS) from the same families, and 183
age- and sex-matched normal healthy children (NN) whose
families did not harbor calcium stone disease. Using these three
populations, we have asked which urine stone risk factors most
differ between stone-forming patients and their non-stone-
forming contrasts: siblings and unrelated people. We find that it
is hypercalciuria itself that differs and not any other factor.
In addition, we find that SS with respect to CaOx and calcium
phosphate (CaP) is higher in the SFs, and the difference between
the SS and that SS at which crystallization begins in vitro—
the upper limit of metastability or ULM—is lower in SFs with
respect to CaP as brushite (CaHPO4). Finally, we can show that
this distance is lower, and hypercalciuria more marked, in children
with multiple stones than in those with only one stone.
RESULTS
Urine excretions
Calcium. Compared with normal children (NN; Figure 1,
upper left panel), SFs and their non-stone-forming siblings (NS)
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excreted more calcium as judged from mean values with
full adjustment for sex, age, and body surface area. Plotted as
a single data point from each subject, the nonparametric
quantile plot of adjusted urine calcium for children with 1–2
or 42 stones each was displaced far to the right of the
distribution for normal children (Figure 2, left panel); the
distribution of adjusted values for siblings of SFs was between
the normal and stone-forming distributions. Adjusted mean
values (Figure 2, right panel) followed the same pattern:
siblings exceeded normals, those with 1–2 stones exceeded
siblings and normals, and those with 42 stones exceeded all
other groups. In the adjustment analysis, we found a small
effect of age on urine calcium, due variably to boys and girls
(Figure 3, upper left panel).
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Figure 1 |Urine stone risk factors. Mean 24-h excretions of calcium (top left), oxalate (top middle), phosphorus (top right), and citrate
(bottom right), as well as urine volume (bottom left) and pH (bottom middle), are shown for children with calcium stones, their non-stone-
forming siblings, and normal healthy children. Values are means±s.e.m., adjusted for gender, age, and body surface area. Significant
differences between subject types were observed only for calcium excretion: *Po0.0001, stone former vs. sibling and stone former vs.
normal; #Po0.03, sibling vs. normal.
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Figure 2 |Calcium excretion and stone formation. Daily calcium excretion is expressed per 1.73m2 body surface area, adjusted for gender
and age. A quantile plot showing the distribution of data for all subjects is on the left, and means±s.e.m. by subject group on the right.
Stone formers are divided into two groups: those who have had 1–2 stones (79 subjects; 34 boys and 45 girls) and those with 42 stones
(50 subjects; 22 boys, 28 girls). Significant differences are as follows: *Po0.0001,42 stones vs. sibling,42 stones vs. normal, and 1–2 stones
vs. normal; wPo0.01, 42 stones vs. 1–2 stones; #Po0.03, 1–2 stones vs. sibling and sibling vs. normal. Stone formers and their siblings
excreted more calcium than their normal counterparts, and calcium excretion was higher in patients with more stones (right panel,
Po0.0001 for the regression).
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Other stone risk measurements. Unlike calcium, we could
find no significant differences for urine oxalate, phosphorus,
volume, pH, or citrate (Figure 1). When graphed by age
sextile (Figure 3, Table 1), we could observe a decrease in
urine citrate per 1.73 m2 body surface area with age among
boys (Po0.001 for the regression), but not girls (Figure 3,
compare upper and lower right panels), and a similar pattern
of decline with age in urine oxalate per 1.73 m2 body surface
area among girls (Po0.001 for the regression), but not boys
(Figure 3, compare upper and lower middle panels).
However, the overlapping and interlocking graphs of normals
and SFs make clear that at no age period could we discern
significant group differences.
Nutrients. Adjusted for sex, age, and body surface area,
urine potassium excretion of SFs and siblings was below that
of normal children (45±1, 39±2, and 38±2 mmol/day
for NN, NS, and SF, respectively; Po0.001 for both NS and
SF vs. NN). Among boys, but not girls, ammonia excretion
of normals exceeded that of SFs (34±1, 31±2, and 27±
2 mmol/day for NN, NS, and SF, respectively; P¼ 0.003 for
NN vs. SF). Similarly, urine urea nitrogen of normal boys
exceeded that of both SFs and their siblings (9.3±0.3,
8.0±0.4, and 7.9±0.4 g/day for NN, NS, and SF, respectively,
Po0.01 for both NS and SF vs. NN). Girls did not differ in
urine urea nitrogen by subject type. Urine sodium excretion
was higher in boys than in girls (156±4 vs. 136±5 mmol/day,
Po0.01). Among all subjects, SF tended to have higher
sodium excretion, but the differences were not significant
(139±5, 145±6, and 153±6 mmol/day for NN, NS, and SF,
respectively; P40.1 for all comparisons). As sodium and
protein intake are known regulators of calcium excretion, we
repeated the calcium analysis by subject type as above,
adjusting additionally for sodium, urine urea nitrogen, and
ammonia excretion. The results were virtually unchanged
from those shown in Figure 1 (110±5, 143±6, and 179±
7 mg/day for NN, NS, and SF, respectively; Po0.001 for all
comparisons). All variance estimates are 1 s.e.m.
Body size. SF girls weighed less than female NS when
adjusted for age (42.7±1.4 kg vs. 48.5±1.7 kg, SF vs. NS,
Po0.05), but neither was different from female NN
(45.2±1.3 kg). There was a tendency for SF boys to weigh
more than male NS or NN, but weights were not significantly
different (50.1±1.4, 49.1±1.8, and 53.0±1.8 kg for NN, NS,
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Figure 3 |Urine calcium, oxalate, and citrate by gender and age. Daily excretions of calcium (left panels), oxalate (middle panels),
and citrate (right panels) are expressed per 1.73m2 body surface area in boys (top panels) and girls (bottom panels) by age sextile. Values
are means±s.e.m. Oxalate declines significantly with age in girls (lower middle panel), and citrate declines with age in boys (upper
right panel); Po0.001 for both regressions.
Table 1 |Distribution of subjects by gender and stone status
Boys Girls
Age (years) NN NS SF NN NS SF Total
o8.7 16 8 5 26 10 5 70
8.7–10.2 22 6 8 7 12 15 70
10.3–12.7 14 10 15 12 6 13 70
12.8–14.5 13 17 7 15 7 9 68
14.6–16.3 17 10 10 11 5 17 70
416.3 15 8 11 15 6 14 69
Abbreviations: NN, normal children; NS, non-stone-forming sibling; SF, stone
formers.
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and SF boys, respectively). However, SF boys had significantly
higher age-adjusted body mass index than NN or NS boys
(SF, 21.9±0.6 kg/m2 vs. NN, 19.9±0.5, Po0.01 or vs. NS,
20.1±0.6 kg/m2, Po0.05 for both comparisons). Body mass
index did not differ in girls by subject type.
Urine SS and ULM
Calcium oxalate. CaOx SS rose progressively from normal
through siblings to SFs (Figure 4, upper left panel, black
circles at lower ends of each bar; Po0.001 for the regression).
Similarly, the SS required to experimentally induce crystal-
lization (ULM; gray circles at upper ends of each bar) rose in
the same manner, and thus the difference between the two
(Figure 4, upper left panel, length of the cross-hatched bars)
remained constant or slightly increased (Po0.001, SF vs.
normal). Just as urine calcium rose with increasing stone
number, CaOx SS also rose, and thus highest values were in
those SFs with 42 stones (Figure 4, lower left panel). This
trend was significant (legend to Figure 4; Po0.001 for the
regression). CaOx ULM rose with CaOx SS within these four
groups, and thus the ULM–SS distance (Figure 4, lower left
panel, length of cross-hatched bars) remained constant or
slightly increased (P¼ 0.003 for each SF group vs. normal).
Calcium phosphate. Similar to CaOx SS, CaP SS of
siblings and SFs exceeded normal, and the upward trend
from normal through siblings to SFs was significant (Figure 4,
upper right panel, black circles at lower ends of bars,
Po0.001 for the regression). However, the CaP ULM did not
rise between siblings and SFs (Figure 4, upper right panel,
gray circles at upper ends of bars), and thus the ULM–SS
distance (Figure 4, length of cross-hatched bars) decreased
markedly (SFoNN or NS, Po0.01 both comparisons).
A decrease in this distance could promote stones because
the ambient SS resides closer to the SS needed to initiate
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Figure 4 |Urine SS and ULM for CaOx and CaP. Calcium oxalate (CaOx) SS and calcium phosphate (CaP) SS by subject group are shown as
black circles at lower ends of each bar in the left and right panels, respectively; the upper limit of metastability (ULM), the supersaturation
(SS) required to experimentally induce crystallization, are the gray circles at upper ends of each bar. Values are means±s.e.m. In the lower
panels, stone formers are divided into two groups: those who have had 1–2 stones and those with 42 stones (see Figure 2). Hatched
bars represent the distance between ambient SS and ULM, an indicator of the capacity of the urine to resist crystallization. CaOx ULM rose
with CaOx SS across the groups from normal to stone former (upper left panel) and from normal through sibling to progressively more
active stone former (lower left panel), and thus the ULM–SS distance (length of cross-hatched bars) remained constant. In stone formers, the
CaP ULM–SS distance decreased markedly (upper right panel, length of cross-hatched bars), most notably among those with 42 stones
(lower right panel), suggesting that the CaP ULM–SS distance may be an important determinant of stone risk. Significant differences in SS
or ULM: *Po0.001 vs. NN; #Po0.01 vs. NS; þPo0.05 vs. NN; yPo0.05 vs. NN. NN, normal children; NS, non-stone-forming sibling.
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crystallization. The change in ULM–SS difference is most
remarkable among SFs with 42 stones (Figure 4, lower
right panel) whose CaP ULM actually decreased despite a
marked increase in CaP SS when compared with values
for either normals, normal siblings, or SFs with 1–2 stones
(CaP ULM–SS distance for 42 stones o NN or NS,
Po0.001; Po0.01 vs. 1–2 stones). The upward trend in CaP
SS progressing from normals through SFs with 42 stones
was statistically significant (legend to Figure 4; Po0.001 for
the regression).
Crystal growth inhibition
We measured the ability of urine to slow the growth of CaOx
seed crystals incubated in a stirred supersaturated CaOx
solution. To do this (Methods), an equal amount of dialyzed
protein from each urine sample was added to the seeded
system before crystallization was initiated. We could find no
differences between boys and girls or between normals,
siblings, or SFs (Figure 5, left panel). Urine protein from the
youngest children inhibited crystal growth to about 47% of
that found in a solution containing no inhibitory protein
(Figure 5, right panel). With age, the inhibition effect waned,
and thus crystal growth rose progressively.
DISCUSSION
Among all established calcium stone risk factors, we could
identify only hypercalciuria as discriminating between
normal and stone-forming children. In particular, otherwise
critical differences in urine chemistry found between adult
normals and SFs, such as hyperoxaluria, hypocitraturia,
abnormal urine pH, or low urine volume, were not found.
Because our groups were selected by a range of physicians in
many practices, for having stones or relatives with stones, or
for being a normal child with no family history of stones, the
isolated differences of urine calcium cannot reasonably be
ascribed to anything but stones themselves. Moreover, as
stone forming cannot change urine calcium, we can presume
that the hypercalciuria was selected for because it caused the
stone formation. From this reasoning, we suggest that among
children the principal risk factor for calcium stone formation
is hypercalciuria.
Because hypercalciuria is inherited,3 we are not surprised
to find it far more prevalent among siblings of SFs than
among unselected normal children. However, we would not
have a priori predicted that the magnitude of hypercalciuria
might be greater in those with stones than among their
siblings. The fact that hypercalciuria of siblings is signifi-
cantly less marked than that of SFs strongly supports the
hypothesis that hypercalciuria itself is a principal cause of
stones.
The accepted link between urine calcium and stones is the
degree of SS, because SS is a gauge of the thermodynamic
driving force for crystal nucleation and growth.6,16,17 In fact,
both CaOx SS and CaP SS of SFs exceeded those of siblings
and normals in a pattern that paralleled differences in
urine calcium. This parallel is expected, as the other main
determinants of SS, urine volume, oxalate and citrate
excretion, and pH did not differ between the three groups.
Taken with differences in urine calcium, the SS measurements
support the hypothesis that hypercalciuria in children is a
principal stone risk factor acting via the increase of both
CaOx SS and CaP SS. The vast majority of pediatric stones
are calcium,18 and recruiting practices for this study excluded
those with detectable systemic disease or stones known not to
be calcium. From this we would presume that a majority had
CaOx stones, which would be promoted by a high CaOx SS.
We have shown that an initial CaP nucleation may be a
crucial step in the initiation of CaOx stones,19 and thus the
increased CaP SS in stone-forming children may have as
crucial a role as the increased CaOx SS.
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Figure 5 |Calcium oxalate (CaOx) crystal growth inhibition. Crystal growth is shown as mean±s.e.m. percent control growth for children
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The ULM is an empirical estimate of the SS needed to
initiate crystallization.20 The smaller the difference between
the ULM and SS, the closer is the ambient SS to that needed
for crystallization21–23 and therefore the greater the risk that
crystallization and stones will occur. We have observed
among adult men and women that the CaOx ULM rises
proportionally to CaOx SS, and thus the ULM–SS distance
remains reasonably constant comparing SFs with normals,
but the CaP ULM–SS distance is smaller in both male and
female SFs than corresponding normals because CaP ULM
does not rise in proportion to CaP SS.24,25 This, too, is
consistent with the idea that CaP nucleation has a role in
calcium stone genesis even when stones are predominantly
CaOx.
Our children with stones manifest the same pattern as we
observed in adults: among SFs, the CaP ULM–SS distance is
less than that of siblings or normals. Remarkably, among the
siblings CaP SS is higher than normal because of hyper-
calciuria, but CaP ULM is also higher and thus the ULM–SS
distance is normal, whereas among SFs the CaP ULM
remains identical to that of siblings despite a marked rise in
CaP SS. In other words, siblings are hypercalciuric and
consequently have a higher CaP SS than normal, but can
increase CaP ULM, and thus the critical ULM–SS distance
remains normal. Adult SFs and children with stones do not
seem able to maintain this distance, for reasons that are not
within the scope of this research. Until now, the ULM–SS
distances have not been documented for hypercalciuric
non-stone-forming cohorts such as our siblings; thus, this
is a unique and novel observation that clearly points toward
a need for additional research.
The loss of CaP ULM–SS distance was most striking in
children with 42 stones. This is most compatible with the
supposition that the CaP ULM–SS distance is a crucial
determinant of whether stones will form. In fact, the CaP
ULM of children with 42 stones was below that of the other
groups, accentuating the loss of distance as CaP SS rose. We
have no reason to presume that forming more stones will
reduce CaP ULM; at present, no mechanisms exist to create
such a link. For this reason, we propose that the CaP ULM–SS
difference is indeed a graded risk factor, at least among
children, and marks not only whether stones will form or not
but possibly whether stone recurrence is more likely. This
supposition deserves new research that goes beyond the
scope of the present work.
The existence of a ULM–SS distance in a 24-h urine shows
that factors in the urine are retarding crystallization; simple
solutions supersaturated with CaOx and CaP, similar to our
urine, would not remain stable for a period of days. Many
crystallization inhibitors are known to be present in urine,
including small molecules, proteins, proteoglycans, and
glycosaminoglycans.5,6,26–28 Their aggregate activity has been
assayed by us and others using seeded and unseeded crystal
assays.29–35
Our assay of nucleated CaOx crystal growth reveals a
gradual loss of urine inhibition with age. One would assume
that such inhibition would slow and even stop CaOx
initial crystallization, and that loss of inhibition with age
might permit stone formation to increase. It is certainly
true that the prevalence of stones is much higher among
adults than unselected children,36,37 and because idiopathic
hypercalciuria is inherited the trait is present from birth;
therefore, our findings suggest a possible reason why a fixed
risk factor—hypercalciuria—might manifest its consequence—
stone formation—increasingly with age. However, we were
unable to detect any differences in growth retardation between
our three groups, and thus at least this assay fails to provide
any insight as to why stones formed in these children
compared with their siblings and normal children. Similarly,
our assay offers no clue as to the low ULM–SS distance in
the SFs.
Adults display a wider range of urine risk factors
compared with children, which includes reduced urine
citrate, increased urine oxalate, and increased uric acid
excretions.5,38 Possibly all these reflect diet variations that
conspire to increase stone risk.2 The fact that children with
stones should differ from normal children only in urine
calcium, and adults with stones should differ in many more
traits, suggests that some real differences exist between adults
and children. One may be urine volume, which averages
about 1.1 liters daily in children (Figure 1) and about
1.4–1.5 liters daily in adults.39 Isolated hypercalciuria may
be more effective in stone genesis given low volumes, whereas
in adults more abnormalities are needed. This is a speculation
that can be considered in other clinical researches.
In the course of our work, we noted lower urine
potassium excretion in SFs and their siblings than in
normals; moreover, stone-forming boys, but not girls, had
significantly lower urine ammonia and urea nitrogen
excretions than their normal counterparts. This pattern is
compatible with a higher intake of fruits and vegetables in
normal children and lower protein intake in the boys of
stone-forming families compared with normal boys. Lower
protein would imply a lower acid load and therefore a lesser
demand for ammonia excretion. This was noted incidentally
and is not part of our primary research intent. However,
because acid load from protein increases urine calcium,2,40
the lower protein intake of the hypercalciuric SFs and their
siblings would have fostered a lesser increase of urine
calcium. Urine sodium was not different in SF compared
with the other groups, which suggests that hypercalciuria in
children is not as diet dependent as in adults as neither
sodium nor protein intake was higher in SF. Although diet
calcium intake cannot be estimated from the urine calcium
excretion, a great proportion of diet calcium would come
from dairy products, which also provide protein, and thus it
seems unlikely that calcium intake was higher in SF. We
might speculate that the diets of SFs contained more
carbohydrate and fat in place of protein, but because we
did not make specific measurements we do not propose that
our data can substantiate this speculation. However, we did
find that body mass index, which has been shown to correlate
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with measures of body fat in children and adolescents, was
higher in SF boys than in their normal or sibling counter-
parts.41 This supports the idea of dietary differences
contributing to stone risk in boys, as high body mass index
has been shown to be associated with increased CaP SS in
children with nephrolithiasis.42
Our results are in agreement with those of previous
studies that have shown hypercalciuria to be the primary risk
factor for calcium stone formation in children.10,13 Similar
to DeFoor et al.,12 we have also shown calcium excretion to
be significantly higher in subjects with more stones. Other
investigators have identified hypocitraturia as a common risk
factor along with hypercalciuria,11,14,15 and still others have
reported hypocitraturia alone to be the most important risk
factor.43,44 We have found no evidence for hypocitraturia
among the SFs we studied here. This disparity may perhaps
be attributed to geographic differences in study populations,
as the studies reporting the primacy of hypercalciuria were
conducted in the United States, whereas those reporting
hypocitraturia were carried out elsewhere (Turkey, Argentina,
and Scotland).
DeFoor et al.13 found SS levels of CaOx, but not CaP,
to be significantly higher in stone-forming children com-
pared with normal controls. Our results are similar for CaOx,
but, in addition, we found higher CaP SS in SF compared
with the normal or sibling groups. It is possible that the
larger, age-matched population in the present study allowed
the difference in CaP SS to be detected. In fact, our results
point to CaP SS as a key determinant of stone risk as
evidenced by the marked loss of resistance to CaP crystal-
lization (reduced ULM–SS distance) in children with
42 stones.
A crucial limitation of our study is rigorous ascertainment
of controls. Some siblings of SFs without manifest stones may
indeed have formed stones that were silent. Visualization
studies were impossible in our study design. Similarly, we do
not have stone analyses for all of the stone-forming patients,
although we can be very certain from their urological history
and treatment that they did indeed form kidney stones.
Uric acid and cystine stones have evident clinical charac-
teristics, and the latter is often familial, and thus it is likely
that most, if not all, of our patients formed calcium stones;
i.e., clinicians excluded the two uncommon stone types
effectively.
Overall, children with calcium stones differ from normal
children matched by age and sex in having a higher level of
urine calcium excretion with resulting high SS for CaOx and
CaP, and in having a reduced ULM–SS distance for CaP,
which is unexplained at present. The remaining established
risk factors found in adults are not apparently having a role
in children. Because idiopathic hypercalciuria is a common
trait, by definition representing 5% of humans, and stones
are much less prevalent, especially in children, other
abnormalities are presumably present.45 Management of
these children should be similar to that of adults. For the
siblings, maintaining a high urine volume and low sodium
intake, both measures known to reduce stones,46,47 seems
practical and prudent.
MATERIALS AND METHODS
Study subjects
In collaboration with six practices within the Litholink network that
treat primarily pediatric patients, we obtained 24-h urine collections
from 417 children aged 6–17 years. A total of 129 subjects (56 boys
and 73 girls) were clinically considered to be calcium kidney SFs
as determined by stone analysis, visualization of calculi on X-ray,
or based on physician records. Children with non-calcium stones or
any known kidney disease, including cystinuria and primary hyper-
oxaluria, were excluded. In all, 105 subjects (59 boys and 46 girls) were
NS of these calcium SFs, and 183 subjects (97 boys and 86 girls) were
NN with no family history of stone disease. We included only subjects
who were not taking medications that could affect stones or mineral
metabolism such as thiazide and other diuretic agents, vitamin D
supplements, and alkali supplements. Data regarding height and
weight were provided by physicians. The racial backgrounds of the
subjects were Caucasian (74%), Asian (6%), and African American
(1%), with 5% of subjects reporting more than one race and 17%
unreported. Siblings were not recruited via a random sampling
protocol. Although siblings were selected by individual physicians
without any protocolized criteria and should therefore simply parallel
selection of patients, we cannot rigorously exclude potential biases
such as over-selection of siblings of patients with more severe disease.
Imaging studies were not practical, and therefore we cannot be certain
that NSs were not harboring silent stones. This study was approved
by the Western Institutional Review Board (protocol #20050049) and
additional Institutional Review Boards at collaborating practices.
Laboratory measurements
Conventional studies. Each participant was sent a kit contain-
ing materials to collect a 24-h urine specimen and to return five
50-ml aliquots to the Litholink laboratory. Established urine stone
risk factors including calcium, oxalate, citrate, phosphate, magne-
sium, uric acid, sulfate, ammonium, chloride, potassium, sodium,
and pH were measured as described elsewhere.48 Urine creatinine
was measured to assess the completeness of collection. SS for CaOx,
calcium phosphate, and uric acid were calculated using EQUIL2.49
Urine crystallization studies. We measured the ability of urine,
obtained from these children, to inhibit CaOx crystal growth in vitro
using a seeded crystallization system and a constant amount of
dialyzed urine protein (20 mg), as we have already published.29
A modification of the method described by Nicar et al.23 was used to
determine the ULM of CaOx and CaP in human urine as we have
previously described.24 Briefly, an aliquot of urine was centrifuged
for 30 min at 3000 r.p.m. to remove debris. Urine pH was adjusted to
either pH 6.0 for CaOx ULM or pH 6.4 for CaP ULM by the
addition of HCl or NaOH as required. For CaOx ULM, 10 ml of
each urine sample was placed into each of 13 tubes, and sodium
azide was added to each tube, at a final concentration of 0.02%, to
prevent bacterial growth. The tubes were placed in a water bath at
371C and magnetically stirred. To initiate CaOx precipitation,
increasing amounts of sodium oxalate were added to each set of
tubes. A tube with no oxalate added served as a blank. After 3 h,
the samples were checked for visible precipitation; the tube with
the lowest amount of oxalate added that initiated crystallization
was considered the end point. The SS at the point of precipi-
tation was calculated using EQUIL2, assuming that all chemical
1146 Kidney International (2012) 81, 1140–1148
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concentrations were unchanged except for oxalate, which was
taken as the initial measured oxalate concentration plus the amount
added to the tube. CaP ULM was determined in the same manner,
except that calcium chloride was added to the urine samples to
precipitate CaP.
Statistical analysis
We performed analysis of variance to determine differences in
laboratory values comparing subjects by type (normal, sibling, or
SF) or age group. For determination of age groups, we divided
the 417 subjects into six equal groups (sextiles) of approximately
70 subjects each using statistically determined age cut points
(Table 1). We performed post hoc hypothesis testing by subject type
and/or gender as appropriate. Linear regression analysis was used to
assess the relationship between crystal growth inhibition and age. All
statistical calculations were performed using the Systat 11 software
(Systat Software, Chicago, IL).
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